In addition, CDKN2A might also participate in multiple signaling pathways, among which the first five most significant pathways can be seen in Fig. 5B, indicating that the mechanism of CDKN2A in SCLC may be complex. This evidence concerns the gene CDKN2A and small cell lung carcinoma.